banner

Global Antibiotics Market Is Expected To Reach At A CAGR Of 3.86% Between 2024 And 2032

08-Sep-2026 | Zion Market Research

Antibiotics Market Analysis

According to the report, the global antibiotics market size was valued at approximately USD 39.44 billion in 2023 and is projected to reach around USD 54.87 billion by the end of 2032, expanding at a CAGR of approximately 3.86% from 2024 to 2032.

Global Antibiotics Market Size

Supportive Legislation By Government Is Predicted To Speed Up The Process Of Approval, Thereby Powering The Global Market

Supportive legislation by the government is predicted to speed up the process of approval, thereby powering the global market. GAIN Act has terms that facilitate the growth of treatments against pathogens resistant to antibiotics. Diarrhea remains the major cause of death amongst kids all over the world, and it needs antibiotic intervention to stop the morbidity. Other transferable diseases detected to pose a huge burden are pneumonia, AIDS/HIV, tuberculosis, and malaria.

In addition to this, the appearance of new infections, such as the Ebola and Zika viruses, is also powering the uptake and development of antibiotics. Tactical plans of mutual development to split the expenditure are now being normally used by market players. This is predicted to lead to the growth of an extra number of molecules. Moreover, private-public partnerships, where innovative R&D approaches and funds are enhanced by public agencies to antibiotics makers, will further power the creation of new pipeline products.

Antibiotics Market

Antibiotics Market: Report Scope

Report Attributes Report Details
Report Name Antibiotics Market
Market Size in 2023 USD 39.44 Billion
Market Forecast in 2032 USD 54.87 Billion
Growth Rate CAGR of 3.86%
Number of Pages 240
Key Companies Covered Novartis AG, Bayer AG, Janssen Pharmaceuticals, Astellas Pharma, Inc., Pfizer, Inc., GlaxoSmithKline plc, Bristol Myers Squibb Company, Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, and others.
Segments Covered By Action Mechanism, By Drug Class, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 - 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Asia Pacific To Power The Global Market Growth Due To High Occurrence Of Infectious Diseases

Asia Pacific had a noteworthy share earlier due to the high occurrence of infectious diseases, huge population base, greater employment of generic medicines, and regulation reforms. North America had a considerable share of the market in 2023. The North American healthcare system facilitates the employment of branded goods. On the other hand, with the loss of individuality of specific molecules, sales in this area dropped considerably in the last few years.

Latin America, particularly Brazil, with its solid development in the pharmaceuticals industry, is also predicted to show remunerative development. An outbreak of specific viruses in Africa added to the development of the global market in this region.

Browse the full “Antibiotics Market By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors ), By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others), And By Region - Global Industry Perspective, Size, Trends, Comprehensive Analysis, And Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/antibiotics-market

Some of the major players in the global market are Novartis AG, Bayer AG, Janssen Pharmaceuticals, Astellas Pharma, Inc., Pfizer, Inc., GlaxoSmithKline plc, Bristol Myers Squibb Company, Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, and others.

The global antibiotics market is segmented as follows:

By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors

By Drug Class

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides
  • Other

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com